Holding(s) in Company
On October 16, 2025, Renalytix PLC announced that UBS Group AG's holdings in the company fell below the 5% reporting threshold on October 15, 2025. This change is due to an increase in the total number of voting rights. UBS Group AG's voting rights attached to shares decreased to 0.000000%, from a previous notification of 8.324083%. The percentage of voting rights through financial instruments remains at 0.000000%. Consequently, the total voting rights held by UBS Group AG in Renalytix PLC is now 0, down from a previous total that triggered reporting requirements.
Select text to share a quote on X · sign in to keep highlights & notes in your RENX notes
- Reason for the notification (please mark the appropriate box or boxes with an "X")
| An acquisition or disposal of voting rights | X |
| An acquisition or disposal of financial instruments | |
| An event changing the breakdown of voting rights | X |
| Other (please specify) iii : Increase in the total number of voting rights resulting in UBS' trading book holdings in Renalytix PLC fell below 5% and are therefore exempt from reporting. | X |
Details of person subject to the notification obligation iv
| Name | UBS Group AG - Investment Bank & Global Wealth Management |
| City and country of registered office (if applicable) | Z ürich Switzerland |
Full name of shareholder(s) (if different from 3.) v
Name
City and country of registered office (if applicable)
| 5. Date on which the threshold was crossed or reached vi : | 15 October 2025 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 16 October 2025 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 0.000000% | 0.000000% | 0.000000% | 0 |
| Position of previous notification (if applicable) | 8.324083% | 0.000000% | 8.324083% | |
| A: Voting rights attached to shares | ||||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | ||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) | |
| GB00BYWL4Y04 | 0 | 0.000000% | ||
| SUBTOTAL 8. A | 0 | 0.000000% | ||
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
UBS Group AG
UBS AG
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
Increase in the total number of voting rights resulting in UBS' trading book holdings in Renalytix PLC fell below 5% and are therefore exempt from reporting.
| Place of completion | Zurich, Switzerland |
|---|---|
| Date of completion | 16.10.2025 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.